4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000044
President and CEO sold 5,443 shares at $1.81 ($9,863)
- President and CEO acquired 10,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Brunn Carsten · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-01 | Exercise or conversion : show line 1 in the form | +10,937 | 528,895 | D | ||
| 2022-03-02 | Sale : show line 2 in the form | −5,443 | $1.81 | $9,863 | 523,452 | D |
| Open-market sales · 5,443 sh · avg $1.81 · $9,863 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,937 | 32,813 | D |
Loading xslF345X03/wf-form4_164634331527341.xml…